Jevtovic et al. found that systemically applied IL-33 could restrict primary melanoma growth, while the intranasally applied IL-33 promoted the growth of melanoma lung metastases through reducing the cytotoxicity of CD8+ T cells and enhancing regulatory T (Treg) cells [14]. The gene discussed is CD8A; the disease is melanoma.